Safety Profile of Tirzepatide in Long-Term Use The safety profile of tirzepatide shows that it is good for long-term use
These include: Nausea (very common, may affect more than 1 in 10 people) Diarrhoea (very common) Vomiting (common, may affect up to 1 in 10 people) Constipation and abdominal pain (common) Decreased appetite (very common) These gastrointestinal symptoms typically diminish over time as the body adjusts to the medication
There is no direct drug-drug interaction between tirzepatide and vitamin B3 (niacin) documented in the FDA prescribing information for tirzepatide
While celebrities and influencers rave about their dramatic weight loss transformations, they're conspicuously quiet about the symphonic digestive consequences that often accompany this pharmaceutical miracle
Semaglutide, on the other hand, is a GLP-1 receptor agonist, which means it only targets one hormone involved in regulating blood sugar and appetite
This is something she did with the guidance and support of her Ro-affiliated provider
